Louise Dorner Østergaard

Medicin og biovidenskab

1. Prostatic Neoplasms 100%
2. Chemokine CCL2 45%
3. Patient Reported Outcome Measures 44%
4. Erectile Dysfunction 43%
5. Quality of Life 43%
6. Prostatectomy 41%
7. Positron-Emission Tomography 37%
8. Systematic Reviews 29%
9. Ligands 28%
10. Tomography 27%
11. Interviews 26%
12. Clinical Trials 26%
13. Biomarkers 26%
14. Stem Cells 25%
15. Prostate-Specific Antigen 23%
16. Therapeutics 18%
17. Membranes 16%
18. Denmark 12%
19. Progression-Free Survival 10%
20. Serum 10%
21. Health Care Outcome Assessment 9%
22. Animals 8%
23. Research Ethics 8%
24. Sodium Fluoride 7%
25. Guidelines 7%
26. Disease Progression 7%
27. Nurses 6%
28. Proctectomy 6%
29. Recovery of Function 6%
30. Urologists 5%
31. Digital Rectal Examination 5%
32. Watchful Waiting 5%
33. Congresses 5%
34. Brachytherapy 5%
35. Cell- and Tissue-Based Therapy 5%
36. Signal-To-Noise Ratio 5%
37. Multicenter Studies 5%